Comprehensive Psychiatric Evaluation and Patient Case Presentation
Week 7: Comprehensive Psychiatric Evaluation And Patient Case Presentation
Catherine Nwosu
Master of Science in Nursing, Walden University
NRNP 6635-24: Psychopathology and Diagnostic Reasoning
Dr. Tabitha Perrigo
October 17, 2021
Comprehensive Psychiatric Evaluation And Patient Case Presentation
Schizophrenia refers to a serious mental health disorder in which individuals have
problems interpreting reality in a normal way (McCutcheon et al., 2019). Schizophrenia
involves a mix of delusions, hallucinations, and extreme disordered thinking and behavior
that can impact the daily functioning of an individual. Individuals with Schizophrenia often
require lifelong treatment because the disorder impacts their ability to think, feel, and
behave clearly (McCutcheon et al., 2019). It is difficult to identify a specific cause of
Schizophrenia although it is believed to result from a combination of genetics, altered
brain chemistry and structure, and environmental causes (Fond et al., 2021).
Characteristics of Schizophrenia include thoughts or experiences that seem to be out of
touch with reality and reduced participation in daily activities. Treatment for Schizophrenia
often works by combining several strategies as psychotherapy, medications, and
coordinated specialty care services (Fond et al., 2021). Schizophrenia falls under
psychotic disorders and it affects less than 1% of individuals in the United States (Fond et
al., 2021).
Conducting a comprehensive evaluation during the assessment and diagnosis of
patients with Schizophrenia is important to pinpoint the exact factors that point to
Schizophrenia as the primary diagnosis. This paper is aimed at constructing a
comprehensive psychiatric evaluation that comprises of differential diagnosis and
reflection notes about a patient who is presenting with symptoms of Schizophrenia.
CC (chief complaint): " I have lots of issues at work and it is stressing me out.”
HPI: The patient is a 39-year-old female who presents to the clinic via telehealth with
consent obtained complaints of having lots of issues at work which stress her out. The
© 2020 Walden University Page 2 of 10
patient explains that she is currently seeing a new psychiatrist because her previous
provider does not accept health insurance anymore. The patient explains that she has a
history of a past diagnosis of Schizophrenia in 2018 after having an episode. She
explains that the job she had during that time presented some issues that significantly
contributed to her symptoms. She admits to being admitted to a psychiatric hospital in
2018 where the diagnosis of Schizophrenia was made. The patient was initially
prescribed Zoloft 20MG together with injections of Aristada for 1.5 years. However, she
explains that she stopped taking the injections because she could not afford it. Recently,
the patient began taking Risperidone 2MG. Other current medications include
Risperidone 2 MG Oral Tablet, Fluoxetine HCl 20 MG Oral Capsule, and Benztropine
Mesylate 1 MG Oral Tablet. Her father has dementia and no other medical issue is
reported about other family members.
Past Psychiatric History:
General Statement: The patient has a previous diagnosis of Schizophrenia that
was done in 2018.
Caregivers (if applicable): Primary Care Provider
Hospitalizations: the patient was hospitalized back in 2018 in a psychiatric facility.
Medication trials: Risperidone 2 MG Oral Tablet, Fluoxetine HCl 20 MG Oral
Capsule, and Benztropine Mesylate 1 MG Oral Tablet.
© 2020 Walden University Page 3 of 10
Psychotherapy or Previous Psychiatric Diagnosis: the patient has a previous
psychiatric diagnosis of schizophrenia that was done in 2018 during her
hospitalization.
Substance Current Use and History: explains that she does not smoke although she
admits to social drinking at least twice a year.
Family Psychiatric/Substance Use History: father has dementia although apart from
this, there is no other medical health issues reported regarding the other family members.
Psychosocial History: The patient had a normal birth and grew up with both parents.
She obtained her GE and has two siblings. She enjoys going to the movies, watching TV,
and shopping. The patient is a Christian and she explains that she has good appetite.
She admits to being straight or heterosexual and identifies as a female. The patient
explains to having a difficult time maintaining her job although she works for a temp
agency currently and it seems to be going well. The patient is not in a relationship and
denies any sexual activity. She lives alone and the nature of the relationship between her
and her siblings is not provided.
Medical History: Schizophrenia
Current Medications: Risperidone 2 MG Oral Tablet, Fluoxetine HCl 20 MG Oral
Capsule, and Benztropine Mesylate 1 MG Oral Tablet.
Allergies: has no known drug, food, or environmental allergies.
Reproductive Hx: Heterosexual
© 2020 Walden University Page 4 of 10
ROS:
GENERAL: Does not have weight loss, fever, chills, weakness, or fatigue.
HEENT: Does not have visual loss, blurred vision, double vision, or yellow sclerae.
Does not have hearing loss, sneezing, congestion, runny nose, or sore throat.
SKIN: Does not have visible rash or itching.
CARDIOVASCULAR: does not have chest pain, chest discomfort, or chest
pressure. Does not have palpitations or edema.
RESPIRATORY: does not have shortness of breath, cough, or sputum.
GASTROINTESTINAL: Does not have vomiting, nausea, or diarrhea.
GENITOURINARY: does not have burning sensation during urination; the color is
standard; has normal odor.
NEUROLOGICAL: does not have headaches, dizziness, seizures, tremors, ataxia,
paralysis, numbness, or tingling in the extremities.
MUSCULOSKELETAL: Does not have muscle pain, back pain, joint pain, or
stiffness.
© 2020 Walden University Page 5 of 10
HEMATOLOGIC: Does not have anemia, bleeding, or bleeding.
LYMPHATICS: Does not have enlarged nodes. Does not have history of
splenectomy.
ENDOCRINOLOGIC: Does not have reports of sweating, cold, or heat intolerance.
Does not have polydipsia or polyurea.
Physical exam: VITAL SIGNS
Height: 5’9”
Weight; 154 lbs.
BP: 138/76
Temperature: 97.3F
Pulse: 88
Respiratory rate: 20
O2 Saturation: 98%
Pain: No complaint of pain verbalized during evaluation.
Diagnostic tests/results:
Patient Health Questionnaire screening was administered which is a diagnostic
instrument for assessing common mental disorders. It is specifically used in assessing
whether the symptoms presented are in correspondence to those of depression.
Blood tests or MRI could also be used by the provider to rule out any medical conditions.
© 2020 Walden University Page 6 of 10
Assessment
Mental Status Examination:
The patient is a 39-year-old female who looks her stated age. She is oriented to
person, place, time and situation and her general appearance is neat and clean. The
patient has a normal eye contact and psychomotor activity involves repetitive movements.
Her attention is intact and she is cooperative with the examiner. The patient has a normal
speech with a euthymic mood and appropriate affect to her mood. Her thought process is
goal-directed and her thought content is intact. The patient has good perception and
insight with fair judgment and cognition. Her language is appropriate and she has good
immediate, recent, and remote memory. The patient has no suicidal or homicidal
ideations.
Differential Diagnoses:
Schizophrenia
The most likely primary diagnosis for this patient is Schizophrenia. This is because she
has a history of previous diagnosis of Schizophrenia in 2018. It is likely that the patient is
undergoing a relapse of Schizophrenia because according to research, symptoms of
Schizophrenia can get better when it is under control but the individual may undergo a
relapse and the symptoms will come back if it is no longer controlled (Lieberman & First,
2018). This is true for this patient because after being diagnosed with Schizophrenia , she
was put on Zoloft 20MG and was getting injections of Aristada for 1.5 years but later on
stopped taking the injections due to her inability to afford it. The failure to take medicine
© 2020 Walden University Page 7 of 10
as instructed is the most common cause of any relapses in Schizophrenia and is likely to
be the case of the patient (Fond et al., 2021).
Schizoaffective Disorder
This is also a possible diagnosis for the patient because the symptoms for this condition
often resemble those of Schizophrenia with the addition of mood symptoms (Boerrigter et
al., 2017). However, this diagnosis can be ruled out because the symptoms of the patient
are better explained by Schizophrenia disorder especially due to the fact that the patient
has a history of the disorder.
Bipolar Disorder
This is a possible diagnosis for this patient because the patient’s symptoms of having
issues at work that stress her out resemble those of bipolar disorder. This is because
individuals with bipolar disorder are more prone to stress and they have a hard time
recovering from, and adjusting to stressors (Grande et al., 2016). Also, the symptoms for
this disorder are similar to those of Schizophrenia and Schizoaffective disorder making it
a possible diagnosis (Grande et al., 2016). However, the diagnosis is ruled out because
the patient does not report periods of elevated moods and mania or depression which is
characteristic of this condition (Fond et al., 2021). Also, the patient’s a previous history of
Schizophrenia explains her symptoms better.
Plan of Care
The plan includes strategies of continuing to stabilize the symptoms of
Schizophrenia in the next 90 days. It also involves encouraging the patient to complete a
physical and get yearly labs and to adopt positive coping skills such as walking,
© 2020 Walden University Page 8 of 10
journaling, and deep breathing exercises (Fond et al., 2021). The plan of care also
involves encouraging the patient to call 911 in the event of suicidal or homicidal ideations.
Patient is to follow up in two weeks.
Reflections:
In order to successfully controls Schizophrenia, it is important to combine several
approaches such as the use of psychotherapy, medication, and behavioral therapy. It is
important to understand the relapses in Schizophrenia in detail and how they occur. An
element that I would do differently would be obtaining more information about the
patient’s previous psychiatric hospitalization in 2018. One ethical consideration that I
would apply in the case of the patient is establishing a background of her financial
situation to understand reasons that made her unable to afford taking the injections and
her current financial position regarding her ability to obtain prescribed medication.
Conclusion
Schizophrenia is well controlled when a patient is adhering to the treatment plan
including taking the medication because this prevents relapses. It is important to advise
the patient on the possible side effects of the medication and how to manage them. It is
also significant to assess the prescribed medications for the patient and the possible
contraindications that may occur.
© 2020 Walden University Page 9 of 10
References
Boerrigter, D., Weickert, T. W., Lenroot, R., O’Donnell, M., Galletly, C., Liu, D., ... &
Weickert, C. S. (2017). Using blood cytokine measures to define high inflammatory
biotype of schizophrenia and schizoaffective disorder. Journal of
neuroinflammation, 14(1), 1-15.
Fond, G., Pauly, V., Leone, M., Llorca, P. M., Orleans, V., Loundou, A., ... & Boyer, L.
(2021). Disparities in intensive care unit admission and mortality among patients
with schizophrenia and COVID-19: a national cohort study. Schizophrenia
bulletin, 47(3), 624-634.
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016). Bipolar disorder. The
Lancet, 387(10027), 1561-1572.
Lieberman, J. A., & First, M. B. (2018). Psychotic disorders. New England Journal of
Medicine, 379(3), 270-280.
McCutcheon, R. A., Abi-Dargham, A., & Howes, O. D. (2019). Schizophrenia, dopamine
and the striatum: from biology to symptoms. Trends in neurosciences, 42(3), 205-
220.
© 2020 Walden University Page 10 of 10